Terms: = Bone cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
58 results:
1. Disparities in Time to Diagnosis Among Patients With Multiple Myeloma.
Lin OM; Paine D; Gramling E; Menon M
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e379-e385. PubMed ID: 37612207
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
[TBL] [Abstract] [Full Text] [Related]
3. Extra-mandibular Osteoradionecrosis after the Treatment of Head and Neck cancer.
Kovarik PDE; Patil R; Cvek J; Kelly C; Jackson M; Mackenzie L; West N; Willis N; Kovarik JP; Banks R; Kennedy M; Adams J; Iqbal MS
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e498-e505. PubMed ID: 37433701
[TBL] [Abstract] [Full Text] [Related]
4. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
[TBL] [Abstract] [Full Text] [Related]
5. GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis.
Sánchez-Maldonado JM; Cabrera-Serrano AJ; Chattopadhyay S; Campa D; Garrido MDP; Macauda A; Ter Horst R; Jerez A; Netea MG; Li Y; Hemminki K; Canzian F; Försti A; Sainz J
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047000
[TBL] [Abstract] [Full Text] [Related]
6. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the Treatment of Malignant Tumor bone Metastases.
Sang T; Zhang T; Wang J; Zheng Y
Biomed Res Int; 2022; 2022():2055900. PubMed ID: 36440359
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Hattinger CM; Casotti C; Patrizio MP; Luppi S; Fantoni L; Scotlandi K; Ibrahim T; Serra M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233089
[TBL] [Abstract] [Full Text] [Related]
8. Debilitating hip degeneration in trichothiodystrophy: Association with ercc2/xpd mutations, osteosclerosis, osteopenia, coxa valga, contractures, and osteonecrosis.
DiGiovanna JJ; Randall G; Edelman A; Allawh R; Xiong M; Tamura D; Khan SG; Rizza ERH; Reynolds JC; Paul SM; Hill SC; Kraemer KH
Am J Med Genet A; 2022 Dec; 188(12):3448-3462. PubMed ID: 36103153
[TBL] [Abstract] [Full Text] [Related]
9. Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.
Pratz KW; Panayiotidis P; Recher C; Wei X; Jonas BA; Montesinos P; Ivanov V; Schuh AC; DiNardo CD; Novak J; Pejsa V; Stevens D; Yeh SP; Kim I; Turgut M; Fracchiolla N; Yamamoto K; Ofran Y; Wei AH; Bui CN; Benjamin K; Kamalakar R; Potluri J; Mendes W; Devine J; Fiedler W
Blood Cancer J; 2022 Apr; 12(4):71. PubMed ID: 35443742
[TBL] [Abstract] [Full Text] [Related]
10. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System Tumors.
Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
[TBL] [Abstract] [Full Text] [Related]
11. Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.
Williams L; Doucette K; Karp JE; Lai C
Bone Marrow Transplant; 2021 Jul; 56(7):1535-1549. PubMed ID: 33686252
[TBL] [Abstract] [Full Text] [Related]
12. Estimation of [177Lu]PSMA-617 tumor uptake based on voxel-wise 3D Monte Carlo tumor dosimetry in patients with metastasized castration resistant prostate cancer.
Götz TI; Lang EW; Prante O; Cordes M; Kuwert T; Ritt P; Ludwig B; Schmidkonz C
Nuklearmedizin; 2020 Sep; 59(5):365-374. PubMed ID: 32663888
[TBL] [Abstract] [Full Text] [Related]
13. DNA repair genes hOGG1, XRCC1 and ercc2 polymorphisms and their molecular mapping in breast cancer patients from India.
Rajagopal T; Seshachalam A; Rathnam KK; Jothi A; Viswanathan S; Talluri S; Dunna NR
Mol Biol Rep; 2020 Jul; 47(7):5081-5090. PubMed ID: 32519309
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based study.
Godtman RA; Månsson M; Bratt O; Robinsson D; Johansson E; Stattin P; Kjölhede H
Scand J Urol; 2019 Dec; 53(6):378-384. PubMed ID: 31805808
[No Abstract] [Full Text] [Related]
15. Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE "too young to get cancer?" study.
Dommett RM; Pring H; Cargill J; Beynon P; Cameron A; Cox R; Nechowska A; Wint A; Stevens MCG
BMC Cancer; 2019 Jun; 19(1):616. PubMed ID: 31234813
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon cancer.
Gao Z; Fu P; Yu Z; Zhen F; Gu Y
Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
[TBL] [Abstract] [Full Text] [Related]
17. ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
Chen XJ; Tong ZC; Kang X; Wang ZC; Huang GL; Yang TM; Dong L
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6658-6666. PubMed ID: 30402838
[TBL] [Abstract] [Full Text] [Related]
18. Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
Cella D; Escudier B; Tannir NM; Powles T; Donskov F; Peltola K; Schmidinger M; Heng DYC; Mainwaring PN; Hammers HJ; Lee JL; Roth BJ; Marteau F; Williams P; Baer J; Mangeshkar M; Scheffold C; Hutson TE; Pal S; Motzer RJ; Choueiri TK
J Clin Oncol; 2018 Mar; 36(8):757-764. PubMed ID: 29377755
[TBL] [Abstract] [Full Text] [Related]
19. New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome.
Santiago SP; Junior HLR; de Sousa JC; de Paula Borges D; de Oliveira RTG; Farias IR; Costa MB; Maia ARS; da Nóbrega Ito M; Magalhães SMM; Pinheiro RF
Leuk Res; 2017 Jul; 58():73-82. PubMed ID: 28472728
[TBL] [Abstract] [Full Text] [Related]
20. Genetic polymorphisms in ERCC1 and ercc2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
Zhang H; Ge J; Hong H; Bi L; Sun Z
World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
[TBL] [Abstract] [Full Text] [Related]
[Next]